A549 cells infected with RSV Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ATF2 | hg19_v2_chr2_-_176032843_176032941 | 0.87 | 1.3e-01 | Click! |
ATF1 | hg19_v2_chr12_+_51158263_51158395 | 0.64 | 3.6e-01 | Click! |
ATF3 | hg19_v2_chr1_+_212738676_212738755 | 0.36 | 6.4e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.5 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 1.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 1.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 1.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 1.0 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 1.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 1.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.8 | GO:1990709 | maintenance of synapse structure(GO:0099558) presynaptic active zone organization(GO:1990709) |
0.3 | 0.8 | GO:0070512 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.2 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 1.4 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 1.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 1.3 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 1.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 0.8 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
0.0 | 0.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 1.3 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.2 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.0 | 1.1 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 1.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.7 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 1.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 1.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 1.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.7 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |